Pep2Tango Therapeutics, Inc. — Form D
Pep2Tango Therapeutics, Inc. of POTOMAC, MD, a company, filed a Form D exempt-offering notice with the SEC on 2024-11-21. The offering totals $16.7M, of which $16.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-11-21
- Form: D
- Accession: 0002040766-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $16.7M
- Amount sold: $16.7M
- Investors: 12
- Date of first sale: 2024-09-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-530055
Issuer
- Name: Pep2Tango Therapeutics, Inc.
- CIK: 0002040766
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 12050 WETHERFIELD LANE, POTOMAC, MD, 20854
- Phone: 703.201.2978
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Soumitra Ghosh | Director | Potomac, MD |
| Mickey Kim | Director | Potomac, MD |
| Carlo Rizzuto | Director | Littleton, CO |
| Cristina Rondinone | Director | Potomac, MD |
| Cristina Rondinone | Executive Officer | Potomac, MD |
More